Trial reportBMC anesthesiology2026
Median effective dose (ED
Trial report in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThis study aimed to evaluate whether combining esketamine with different doses of propofol could reduce drug requirements and minimize adverse effects in children undergoing gastroscopy.
methodsEighty-eight children scheduled for painless gastroscopy were randomly assigned to four groups receiving propofol at doses of 1, 2, 3, or 4 mg/kg. Esketamine was administered using the Dixon up-and-down sequential method. Failure was defined as coughing, gagging, or airway obstruction during initial gastroscope insertion. The median effective dose (ED50) and 95% confidence intervals were calculated using the up-and-down method and probit regression analysis.
resultsThe ED50 of esketamine decreased significantly with increasing doses of propofol. The ED50 of esketamine combined with propofol 4 mg/kg was significantly lower than that observed with propofol doses of 1, 2, and 3 mg/kg (P < 0.001), and the ED50 with propofol 3 mg/kg was significantly lower than that with propofol 1 and 2 mg/kg (P < 0.05). Recovery time was significantly longer in the propofol 2, 3, and 4 mg/kg groups compared with the 1 mg/kg group, and the incidence of hypotension was higher in the propofol 4 mg/kg group. During recovery, children receiving propofol 1 mg/kg experienced a higher incidence of delirium and visual disturbances. No significant differences were observed in examination time, physician satisfaction, or respiratory depression among the groups.
conclusionCombining esketamine with propofol reduced the esketamine dose required for pediatric gastroscopy in a propofol dose-dependent manner. Among the regimens studied, esketamine combined with 2 mg/kg propofol appears to provide a more favorable balance between anesthetic efficacy and safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.